Association between anti-TNF-αtherapy and interstitial lung disease-Reference-Cited by-同舟云学术

Association between anti-TNF-αtherapy and interstitial lung disease

Published:2013-01-29 Issue:4 Volume:22 Page:394-402
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Herrinton Lisa J.¹,Harrold Leslie R.²,Liu Liyan¹,Raebel Marsha A.³,Taharka Ananse'⁴,Winthrop Kevin L.⁵,Solomon Daniel H.⁶,Curtis Jeffrey R.⁷,Lewis James D.⁸,Saag Kenneth G.⁷

Affiliation:

1. Division of Research; Kaiser Permanente; Oakland; CA; USA

2. Division of Rheumatology, Department of Medicine; University of Massachusetts Medical School, Meyers Primary Care Institute; Worcester; MA; USA

3. Institute for Health Research; Kaiser Permanente Colorado; Denver; CO; USA

4. Department of Pulmonology; Oakland Medical Center, Kaiser Permanente; Oakland; CA; USA

5. Divisions of Infectious Diseases, and Public Health and Preventive Medicine; Oregon Health and Sciences University; Portland; OR; USA

6. Division of Rheumatology, Division of Pharmacoepidemiology; Brigham and Women's Hospital; Boston; MA; USA

7. UAB Center for Education and Research in Therapeutics of Musculoskeletal Disorders; University of Alabama at Birmingham; Birmingham; AL; USA

8. Department of Medicine, Department of Biostatistics and Epidemiology; University of Pennsylvania; Philadelphia; PA; USA

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference21 articles.

1. A systematic review of validated methods for identifying pulmonary fibrosis and interstitial lung disease using administrative and claims data;Jones;Pharmacoepidemiol Drug Saf,2012 Jan

2. Initiation of biologic DMARDs and the risk of hospitalization for infection in patients with autoimmune disease;Grijalva Grijalva;JAMA,2011 Dec 7

3. Association between anti-TNF-α therapy and all-cause mortality;Herrinton;Pharmacoepidemiology and Drug Saf,2012

4. Bosch X; BIOGEAS study group;Ramos-Casals;Pulmonary disorders induced by monoclonal antibodies in patients with rheumatologic autoimmune diseases. Am J Med,2011 May

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring rheumatoid arthritis associated interstitial lung disease a retrospective study from two Saudi tertiary care centers;BMC Rheumatology;2024-08-05

2. TGF-β1 Drives Integrin-Dependent Pericyte Migration and Microvascular Destabilization in Fibrotic Disease;The American Journal of Pathology;2024-07

3. A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritis;Expert Opinion on Drug Safety;2024-05-23

4. Non-Infectious Pneumonitis and Acute Respiratory Distress Syndrome in a Patient on Ustekinumab Treatment: Case Report and Literature Review;Life;2024-03-16

5. Interstitial Lung Disease in Rheumatoid Arthritis: A Review;Cureus;2024-02-05